{"id":37080,"date":"2025-07-10T15:01:06","date_gmt":"2025-07-10T07:01:06","guid":{"rendered":"https:\/\/flcube.com\/?p=37080"},"modified":"2025-07-10T15:01:07","modified_gmt":"2025-07-10T07:01:07","slug":"sironax-partners-with-novartis-on-brain-delivery-module-platform-for-cns-drugs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=37080","title":{"rendered":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs"},"content":{"rendered":"\n<p>China-based biotech innovator <strong>Sironax<\/strong> has entered into a strategic agreement with Swiss pharmaceutical giant <strong>Novartis (NYSE: NVS)<\/strong>, granting Novartis an exclusive option to acquire its groundbreaking <strong>Brain Delivery Module (BDM) platform<\/strong>. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.<\/p>\n\n\n\n<p><strong>Technology Overview<\/strong><br>The <strong>Brain Delivery Module (BDM)<\/strong> represents a significant advancement in CNS drug development. By enabling more effective delivery of therapeutic agents to the brain, this platform addresses a major challenge in treating neurological and neurodegenerative disorders. Sironax retains the rights to continue developing selected programs utilizing the BDM platform during the option period.<\/p>\n\n\n\n<p><strong>Terms of the Agreement<\/strong><br>Under the agreement:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Novartis<\/strong> will conduct comprehensive technical evaluations of the BDM platform.<\/li>\n\n\n\n<li>Should Novartis choose to exercise its exclusive option, it would acquire global exclusive rights to the technology.<\/li>\n\n\n\n<li><strong>Sironax<\/strong> is eligible to receive up to <strong>USD 175 million<\/strong> in combined upfront and near-term payments upon execution of the option.<\/li>\n<\/ul>\n\n\n\n<p><strong>Strategic Implications<\/strong><br>This collaboration underscores the potential of Sironax\u2019s BDM platform to revolutionize CNS drug delivery. For Novartis, the agreement strengthens its pipeline in neurology and neuroscience, aligning with its commitment to innovation in treating complex CNS disorders.<\/p>\n\n\n\n<p><strong>Market Impact<\/strong><br>The partnership highlights the growing importance of technologies that enhance drug delivery to the brain. By addressing the challenges associated with crossing the blood-brain barrier, Sironax\u2019s BDM platform opens new avenues for treating a wide range of CNS conditions, from Alzheimer&#8217;s disease to Parkinson&#8217;s and beyond.<\/p>\n\n\n\n<p><strong>Conclusion<\/strong><br>This strategic agreement between <strong>Sironax<\/strong> and <strong>Novartis<\/strong> not only validates the innovation behind the Brain Delivery Module but also positions both companies at the forefront of CNS drug development. As Novartis evaluates the platform\u2019s potential, Sironax continues its mission to advance anti-aging therapies, demonstrating its versatility and commitment to groundbreaking science.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis&#8230;<\/p>\n","protected":false},"author":1,"featured_media":37081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[140,865,3698],"class_list":["post-37080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-novartis","tag-nyse-nvs","tag-sironax"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=37080\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs\" \/>\n<meta property=\"og:description\" content=\"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=37080\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-10T07:01:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-10T07:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs\",\"datePublished\":\"2025-07-10T07:01:06+00:00\",\"dateModified\":\"2025-07-10T07:01:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080\"},\"wordCount\":322,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1007.webp\",\"keywords\":[\"Novartis\",\"NYSE: NVS\",\"Sironax\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37080#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=37080\",\"name\":\"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1007.webp\",\"datePublished\":\"2025-07-10T07:01:06+00:00\",\"dateModified\":\"2025-07-10T07:01:07+00:00\",\"description\":\"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=37080\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1007.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/1007.webp\",\"width\":1080,\"height\":608,\"caption\":\"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=37080#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs - Insight, China&#039;s Pharmaceutical Industry","description":"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=37080","og_locale":"en_US","og_type":"article","og_title":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs","og_description":"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.","og_url":"https:\/\/flcube.com\/?p=37080","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-10T07:01:06+00:00","article_modified_time":"2025-07-10T07:01:07+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=37080#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=37080"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs","datePublished":"2025-07-10T07:01:06+00:00","dateModified":"2025-07-10T07:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=37080"},"wordCount":322,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=37080#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","keywords":["Novartis","NYSE: NVS","Sironax"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=37080#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=37080","url":"https:\/\/flcube.com\/?p=37080","name":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=37080#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=37080#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","datePublished":"2025-07-10T07:01:06+00:00","dateModified":"2025-07-10T07:01:07+00:00","description":"China-based biotech innovator Sironax has entered into a strategic agreement with Swiss pharmaceutical giant Novartis (NYSE: NVS), granting Novartis an exclusive option to acquire its groundbreaking Brain Delivery Module (BDM) platform. This cutting-edge technology is designed to enhance the efficiency of central nervous system (CNS) drug delivery by improving penetration through the blood-brain barrier.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=37080#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=37080"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=37080#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","width":1080,"height":608,"caption":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=37080#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sironax Partners with Novartis on Brain Delivery Module Platform for CNS Drugs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/1007.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37080"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37080\/revisions"}],"predecessor-version":[{"id":37082,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/37080\/revisions\/37082"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/37081"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}